 Equities analysts expect that Aclaris Therapeutics Inc NASDAQ:ACRS will post earnings per share of 0.26 for the current quarter, according to Zacks. Three analysts have made estimates for Aclaris Therapeutics earnings. The highest EPS estimate is 0.22 and the lowest is 0.30. Aclaris Therapeutics reported earnings per share of 0.56 during the same quarter last ... 